Aperture Venture Partners Iv, L.p. - Net Worth and Insider Trading
Aperture Venture Partners Iv, L.p. Net Worth
The estimated net worth of Aperture Venture Partners Iv, L.p. is at least $1 Million dollars as of 2024-09-20. Aperture Venture Partners Iv, L.p. is the 10% Owner of Trevi Therapeutics Inc and owns about 344,963 shares of Trevi Therapeutics Inc (TRVI) stock worth over $1 Million. Details can be seen in Aperture Venture Partners Iv, L.p.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Aperture Venture Partners Iv, L.p. has not made any transactions after 2019-05-09 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Aperture Venture Partners Iv, L.p.
Aperture Venture Partners Iv, L.p. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Aperture Venture Partners Iv, L.p. owns 1 companies in total, including Trevi Therapeutics Inc (TRVI) .
Insider Ownership Summary of Aperture Venture Partners Iv, L.p.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TRVI | Trevi Therapeutics Inc | 2019-05-09 | 10 percent owner |
Aperture Venture Partners Iv, L.p. Latest Holdings Summary
Aperture Venture Partners Iv, L.p. currently owns a total of 1 stock. Aperture Venture Partners Iv, L.p. owns 344,963 shares of Trevi Therapeutics Inc (TRVI) as of May 9, 2019, with a value of $1 Million.
Latest Holdings of Aperture Venture Partners Iv, L.p.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TRVI | Trevi Therapeutics Inc | 2019-05-09 | 344,963 | 3.50 | 1,207,371 |
Holding Weightings of Aperture Venture Partners Iv, L.p.
Aperture Venture Partners Iv, L.p. Form 4 Trading Tracker
According to the SEC Form 4 filings, Aperture Venture Partners Iv, L.p. has made a total of 0 transactions in Trevi Therapeutics Inc (TRVI) over the past 5 years. The most-recent trade in Trevi Therapeutics Inc is the acquisition of 112,000 shares on May 9, 2019, which cost Aperture Venture Partners Iv, L.p. around $1 Million.
Insider Trading History of Aperture Venture Partners Iv, L.p.
- 1
Aperture Venture Partners Iv, L.p. Trading Performance
GuruFocus tracks the stock performance after each of Aperture Venture Partners Iv, L.p.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Aperture Venture Partners Iv, L.p. is -40.12%. GuruFocus also compares Aperture Venture Partners Iv, L.p.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Aperture Venture Partners Iv, L.p. within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Aperture Venture Partners Iv, L.p.'s insider trading performs compared to the benchmark.
Performance of Aperture Venture Partners Iv, L.p.
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 14.69 | | | | | |
| Relative Return to S&P 500(%) | 14.6 | | | | | |
Aperture Venture Partners Iv, L.p. Ownership Network
Aperture Venture Partners Iv, L.p. Owned Company Details
What does Trevi Therapeutics Inc do?
Who are the key executives at Trevi Therapeutics Inc?
Aperture Venture Partners Iv, L.p. is the 10 percent owner of Trevi Therapeutics Inc. Other key executives at Trevi Therapeutics Inc include director & 10 percent owner & See Remarks Jennifer L Good , director & 10 percent owner David P Meeker , and 10 percent owner & Chief Medical Officer Thomas Sciascia .
Trevi Therapeutics Inc (TRVI) Insider Trades Summary
Over the past 18 months, Aperture Venture Partners Iv, L.p. made no insider transaction in Trevi Therapeutics Inc (TRVI). Other recent insider transactions involving Trevi Therapeutics Inc (TRVI) include a net sale of 9,227 shares made by Lisa Delfini , a net sale of 90,795 shares made by Jennifer L Good , and a net sale of 101,369 shares made by Thomas Sciascia .
In summary, during the past 3 months, insiders sold 113,736 shares of Trevi Therapeutics Inc (TRVI) in total and bought 0 shares, with a net sale of 113,736 shares. During the past 18 months, 205,946 shares of Trevi Therapeutics Inc (TRVI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 205,946 shares.
Trevi Therapeutics Inc (TRVI)'s detailed insider trading history can be found in Insider Trading Tracker table.
Trevi Therapeutics Inc Insider Transactions
Aperture Venture Partners Iv, L.p. Mailing Address
Above is the net worth, insider trading, and ownership report for Aperture Venture Partners Iv, L.p.. You might contact Aperture Venture Partners Iv, L.p. via mailing address: 645 Madison Avenue, 20th Floor, New York Ny 10022.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
